Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Food and Drug Administration headquarters in White Oak, Maryland. Photo: Sarah Silbiger/Getty Images

Seven former FDA commissioners accused the Trump administration of "undermining the credibility" of the agency in a Washington Post op-ed published Tuesday.

Why it matters: The editorial comes amid fears that the Trump administration has politicized the coronavirus response and is seeking expedited approval and distribution of a possible vaccine.

The former commissioners — Robert Califf, Scott Gottlieb, Margaret Hamburg, Jane Henney, David Kessler, Mark McClellan and Andy von Eschenbach — cautioned the White House against taking "the unprecedented step of trying to tip the scales on how safety and benefits [of the vaccine] will be judged."

  • Gottlieb and McClellan sit on the boards of Pfizer and Johnson & Johnson, respectively, both of which are in the process of developing COVID-19 vaccines. Gottlieb, who led the agency for two years under Trump, has become a consistent voice critiquing the U.S. response to the virus.
  • Kessler is an adviser for the Biden campaign.

What they're saying: "[A] safe and effective vaccine will not be enough; people will also have to choose to take it. This depends on widespread confidence that the vaccine approval was based on sound science and not politics."

  • "[T]he perception of political influence matters."
  • "With more than 750 Americans on average dying a day from covid-19, the FDA must be supported to play its unique and essential role. Scientists should make decisions based on data, unfettered by political pressure or the intrusions of ideology or vested interests. Political intrusion only prolongs the pandemic and erodes our public health institutions."

Details: The commissioners cited Trump's comment implying he may reject tougher standards for a coronavirus vaccine and a memo in which Health and Human Services Secretary Alex Azar revoked the FDA's authority to issue new rules on foods, medicines and medical equipment, including vaccines.

  • "These actions are eroding the public’s confidence," the commissioners wrote. "This month, an Axios-Ipsos poll found that 42 percent of Americans lacked trust in FDA decision-making."

Yes, but: "Despite recent political actions, we continue to have confidence in the integrity and high-quality scientific work of FDA staff," the commissioners wrote.

  • "The FDA has already effectively communicated its strict standard for evidence from these trials to the manufacturers, despite comments from the White House. The health professionals whom people still trust won’t recommend a vaccine that hasn’t met the FDA’s standards. Drug makers have also pledged to use the FDA’s scientific standards."

Go deeper: Reports suggest politicization of Trump coronavirus response

Go deeper

Severe coronavirus infections continue to mount

Expand chart
Data: The COVID Tracking ProjectHarvard Global Health Institute; Cartogram: Andrew Witherspoon/Axios

Deaths and severe illness from the coronavirus continue to set new records almost every day, especially in the South and the West.

The big picture: More than 130,000 Americans are in the hospital today with COVID-19 infections. That's straining several states' health care systems and will keep pushing the virus' death toll higher and higher.

Schumer: First priority in new Senate is $2,000 stimulus checks

Senate Minority Leader Chuck Schumer (D-N.Y.) talks with reporters in the Capitol on Jan. 3. Photo: Caroline Brehman/CQ-Roll Call, Inc via Getty Images

Senate Minority Leader Chuck Schumer (D-N.Y.) said Wednesday that one of his first priorities in the 117th Senate will be to pass legislation that would send $2000 stimulus payments.

Why it matters: If Jon Ossoff holds his lead over former Sen. Perdue, Schumer is set to become the next majority leader with the power to steer legislation. The election has not yet been called.

Congressman announces positive COVID-19 test just hours after House floor vote

Rep. Jake LaTurner. Photo: Mark Reinstein/Corbis via Getty Images

Newly elected Rep. Jake LaTurner (R-Kansas) has tested positive for COVID-19 and is following CDC guidelines but is not experiencing any symptoms, per a statement from his office on Thursday morning.

Why it matters: LaTurner voted on the Arizona objection in the Electoral College certification process on Wednesday night, records show. He took the test as part of Washington, D.C'.s requirements and "does not plan to return to the House floor for votes until he is cleared to do so," per the statement.